Hong Kong stocks retreat as Fed decision looms and investors await China signals



Hong Kong stocks slipped on Monday, snapping a two-day rebound, as investors remained cautious about the US Federal Reserve’s decision on interest rate cuts and awaited clearer policy direction ahead of China’s Central Economic Work Conference later this month.

The Hang Seng Index lost 1 per cent to 25,827.26 as of 11.15am local time. The Hang Seng Tech Index rose 0.1 per cent. On the mainland, the CSI 300 Index gained 1 per cent and the Shanghai Composite Index strengthened 0.6 per cent.

Blind-box toymaker Pop Mart International slumped 7.7 per cent to HK$202.20, while biotechnology firm Innovent Biologics tumbled 7.8 per cent to HK$84.80. WeChat operator Tencent Holdings lost 0.8 per cent to HK$605.

Limiting the losses, search-engine giant Baidu jumped 3.6 per cent to HK$126 after it said it is assessing a spin-off listing for its non-wholly owned unit, Kunlunxin (Beijing) Technology. Chinese chipmaker Semiconductor Manufacturing International Corporation advanced 3.5 per cent to HK$72.20, while food-delivery service provider Meituan added 0.5 per cent to HK$99.50.

While the markets widely expected a rate cut this Wednesday, some analysts said the path would be more uncertain next year. Investors are also closely watching for policy clues from the coming economic conference in Beijing, which is expected to set priorities for 2026.

Markets are looking for signals on support measures for technology, consumption and property. Traders are also weighing domestic earnings prospects against lingering concerns about global interest rate policies and geopolitical risks.

  • Related Posts

    China’s AI red-packet battle burns through US$1 billion – but will users stick around?

    In an unprecedented Chinese New Year marketing blitz, Alibaba Group Holding, Baidu, ByteDance and Tencent Holdings spent an estimated 8 billion yuan (US$1.1 billion) to turn their artificial intelligence assistants…

    Continue reading
    Chinese AI drug researcher XtalPi expects to turn first annual profit on 193% revenue jump

    Chinese artificial intelligence-powered drug researcher XtalPi Holdings said it expects to turn its first annual profit on the back of strong revenue growth, according to a corporate filing. The Shenzhen-based…

    Continue reading

    Leave a Reply

    Your email address will not be published. Required fields are marked *